Cargando…
SP1‐induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up‐regulation of PCDH17
Cardiac hypertrophy (CH) is a common cardiac disease and is closely associated with heart failure. Protocadherin 17 (PCDH17) was reported to aggravate myocardial infarction. Present study was designed to illustrate the impact of PCDH17 and the mechanism of PCDH17 expression regulation in CH. CH mode...
Autores principales: | Long, Yadong, Wang, Lin, Li, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339172/ https://www.ncbi.nlm.nih.gov/pubmed/32436661 http://dx.doi.org/10.1111/jcmm.15073 |
Ejemplares similares
-
Comparative characterization of PCDH19 missense and truncating variants in PCDH19-related epilepsy
por: Shibata, Mami, et al.
Publicado: (2020) -
Tripartite motif‑containing 14 may aggravate cardiac hypertrophy via the AKT signalling pathway in neonatal rat cardiomyocytes and transgenic mice
por: Hou, Hongwei, et al.
Publicado: (2023) -
Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2017) -
p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer
por: Chen, Liuxi, et al.
Publicado: (2019) -
Brain calcifications and PCDH12 variants
por: Nicolas, Gaël, et al.
Publicado: (2017)